Jeffrey Capello

CFO

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Biogen Inc. publishes a filing, an earnings call transcript or a press release.

About Jeffrey Capello

Jeffrey Capello is recorded as CFO at Biogen Inc. (BIIB) and Board Member at Agios Pharmaceuticals, Inc. (AGIO). The newest filing on record that lists Jeffrey Capello as Board Member at Agios Pharmaceuticals, Inc. (AGIO) is dated April 24, 2026. The proxy statement of Biogen Inc. reports total compensation of $9,221,511 for Jeffrey Capello in fiscal 2020, including a base salary of $671,132. Disclosed compensation is on record for 4 fiscal years. Jeffrey Capello has spoken on 1 earnings call across 1 company, most recently for Biogen Inc. on July 22, 2020. Biogen Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biogen Inc. includes Christopher A. Viehbacher (CEO and Board Member), Caroline D. Dorsa (Chairman), Michael R. McDonnell (CFO) and 7 others.

Jeffrey Capello on recent calls

“We are pleased that Biogen had another strong quarter despite the COVID-19 challenges as we continued to execute well. We remain in a very strong financial position with significant cash and financial capacity to continue to grow the business over the long term.”

CFO, Biogen Inc. Q2 FY2020 Earnings Call · July 22, 2020

Affiliation history

Biogen Inc. (BIIB)
CFO

Source not stated

Current
Agios Pharmaceuticals, Inc. (AGIO)
Board Member

Proxy statement

Current
Start not stated–present

Last confirmed April 24, 2026

Company network

Biogen Inc.

BIIB

Current role

Drug Manufacturers - General · Healthcare

CFO

1 appearance Latest appearance 2020-07-22

View calls and events

Agios Pharmaceuticals, Inc.

AGIO

Current role

Biotechnology · Healthcare

Board Member

Leadership on record at Biogen Inc.

Christopher A. Viehbacher CEO, Board Member
Caroline D. Dorsa Chairman
Michael R. McDonnell CFO
Sean Godbout Chief Accounting Officer
Christopher Viehbacher Board Member
Eric K. Rowinsky Board Member
Jesus B. Mantas Board Member
Lloyd B. Minor, M.D. Board Member
Lloyd Minor Board Member
Menelas Pangalos Board Member

Leadership on record at Agios Pharmaceuticals, Inc.

Brian Goff CEO, Board Member
Jacqualyn Fouse CEO, Board Member
David P. Schenkein Chairman
Jacqualyn A. Fouse Chairman
Cecilia Jones CFO
T.J. Washburn Chief Accounting Officer
Catherine Owen Adams Board Member
Cynthia Smith Board Member
David Scadden Board Member
David Scadden, M.D. Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2020	Biogen Inc. (BIIB)	Former Executive Vice President and Chief Financial Officer	$671,132	—	$3,901,503	—	—	$4,648,876	$9,221,511
2019	Biogen Inc. (BIIB)	Former Executive Vice President and Chief Financial Officer	$783,173	—	$4,051,891	—	$883,575	$95,450	$5,814,089
2018	Biogen Inc. (BIIB)	Former Executive Vice President and Chief Financial Officer	$750,000	—	$2,889,224	—	$790,913	$46,582	$4,476,719
2017	Biogen Inc. (BIIB)	Executive Vice President and Chief Financial Officer	$28,846	$520,000	—	—	—	$132	$548,978

Recent activity

Earnings call Biogen Inc. Q2 FY2020 Earnings Call Biogen Inc. (BIIB)
2020-07-22